This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
L02B[AG]
1 out of 7 registries used, show all original rules.
12527
Check minimum number of events
Min. number of events
3
12527
Include endpoints None
12527
Remove individuals based on genotype QC
12165
RX_ERPLUS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Medicines for HER+ breast cancer
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 12165 | 11979 | 186 |
| Unadjusted prevalence (%) | 2.95 | 5.20 | 0.10 |
| Mean age at first event (years) | 60.53 | 60.66 | 52.21 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: RX_ERPLUS – Medicines for HER+ breast cancer
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Medicines for HER+ breast cancer
↥Endpoint not on priority list, no data to show.